Clinical characteristics of and response to combination chemotherapy and subsequent application of international prognostic index in non-Hodgkin's lymphoma - An experience from a Medical Center in Southern Taiwan

Kaohsiung Journal of Medical Sciences

Volumn 12, Issue 2, 1996, Pages 69-82

  Hsieh, C I ^a   Su, W C ^a   Chien, C H ^a   Cuo, Y L ^a   Chen, T Y ^a   Kao, R H ^a   Tsao, C J ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

chemotherapy; international index; non Hodgkin's lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FEMALE; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PHENOTYPE; PROGNOSIS; SURVIVAL; T LYMPHOCYTE; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0029877703     PISSN: 02575655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)